What is the current valuation of the US polyps market in 2024?

The overall market valuation was $686.7 Million in 2024. Read More

What is the projected market valuation for the US polyps market by 2035?

The projected valuation for 2035 is $882.5 Million. Read More

What is the expected CAGR for the US polyps market during the forecast period 2025 - 2035?

The expected CAGR for the market during this period is 2.31%. Read More

Which companies are the key players in the US polyps market?

Key players include Medtronic, Boston Scientific, Johnson & Johnson, Olympus Corporation, Stryker Corporation, Cook Medical, Conmed Corporation, and B. Braun Melsungen AG. Read More

What are the market segments based on type of polyps?

Segments include Adenomatous Polyps, Hyperplastic Polyps, Sessile Serrated Polyps, and Traditional Serrated Adenomas. Read More

What were the valuations for Adenomatous Polyps in 2024?

The valuation for Adenomatous Polyps was between $200.0 Million and $260.0 Million in 2024. Read More

What is the market size for colonoscopy as a diagnosis method in 2024?

The market size for colonoscopy as a diagnosis method was between $300.0 Million and $400.0 Million in 2024. Read More

What treatment methods are included in the US polyps market?

Treatment methods include Polypectomy, Medications, Surveillance, and Surgery. Read More

What was the market valuation for adults in the patient demographics segment in 2024?

The market valuation for adults was between $400.0 Million and $520.0 Million in 2024. Read More

How does the market for pediatric patients compare to other demographics?

The market valuation for pediatric patients was significantly lower, at between $86.7 Million and $62.5 Million in 2024. Read More

US Polyps Market

US Polyps Market Research Report By Type (Adenomatous Polyps, Hyperplastic Polyps, Sessile Serrated Polyps, Traditional Serrated Adenomas), By Diagnosis Method (Colonoscopy, Sigmoidoscopy, Endoscopy, Imaging Techniques), By Treatment Method (Polypectomy, Medications, Surveillance, Surgery) and By Patient Demographics (Adults, Senior Citizens, Pediatric) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

2.31%

2024 Market Size

$ 686.7 Million

2035 Market Size

$ 882.5 Million

Pharmaceutical ● Updated August 2026 Report ID: MRFR/Pharma/18471-HCR | Pages: 100 | Author: Satyendra Maurya, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Type (USD Million)
  1. 4.1.1 Adenomatous Polyps
  2. 4.1.2 Hyperplastic Polyps
  3. 4.1.3 Sessile Serrated Polyps
  4. 4.1.4 Traditional Serrated Adenomas
2. 4.2 Life Sciences, BY Diagnosis Method (USD Million)
  1. 4.2.1 Colonoscopy
  2. 4.2.2 Sigmoidoscopy
  3. 4.2.3 Endoscopy
  4. 4.2.4 Imaging Techniques
3. 4.3 Life Sciences, BY Treatment Method (USD Million)
  1. 4.3.1 Polypectomy
  2. 4.3.2 Medications
  3. 4.3.3 Surveillance
  4. 4.3.4 Surgery
4. 4.4 Life Sciences, BY Patient Demographics (USD Million)
  1. 4.4.1 Adults
  2. 4.4.2 Senior Citizens
  3. 4.4.3 Pediatric
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Boston Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Johnson & Johnson (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Olympus Corporation (JP)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Stryker Corporation (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Cook Medical (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Conmed Corporation (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 B. Braun Melsungen AG (DE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY DIAGNOSIS METHOD
4. 6.4 US MARKET ANALYSIS BY TREATMENT METHOD
5. 6.5 US MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
6. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF LIFE SCIENCES
9. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
10. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
11. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
12. 6.12 LIFE SCIENCES, BY TYPE, 2024 (% SHARE)
13. 6.13 LIFE SCIENCES, BY TYPE, 2024 TO 2035 (USD Million)
14. 6.14 LIFE SCIENCES, BY DIAGNOSIS METHOD, 2024 (% SHARE)
15. 6.15 LIFE SCIENCES, BY DIAGNOSIS METHOD, 2024 TO 2035 (USD Million)
16. 6.16 LIFE SCIENCES, BY TREATMENT METHOD, 2024 (% SHARE)
17. 6.17 LIFE SCIENCES, BY TREATMENT METHOD, 2024 TO 2035 (USD Million)
18. 6.18 LIFE SCIENCES, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE)
19. 6.19 LIFE SCIENCES, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY DIAGNOSIS METHOD, 2025-2035 (USD Million)
  3. 7.2.3 BY TREATMENT METHOD, 2025-2035 (USD Million)
  4. 7.2.4 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Polyps Market Segmentation

US Polyps Market By Type (USD Million, 2025-2035)

Adenomatous Polyps
Hyperplastic Polyps
Sessile Serrated Polyps
Traditional Serrated Adenomas

US Polyps Market By Diagnosis Method (USD Million, 2025-2035)

Colonoscopy
Sigmoidoscopy
Endoscopy
Imaging Techniques

US Polyps Market By Treatment Method (USD Million, 2025-2035)

Polypectomy
Medications
Surveillance
Surgery

US Polyps Market By Patient Demographics (USD Million, 2025-2035)

Adults
Senior Citizens
Pediatric

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”